Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3034 |
|
| Actual shortage: | 241 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2766 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-08-08 | 2017-09-22 | 18543 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-08-01 | 55299 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-10-16 | 2019-11-18 | 96647 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-06 | 2020-09-04 | 121903 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-08-26 | 2020-09-02 | 122994 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-23 | 2023-03-02 | 179444 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-23 | 2023-03-02 | 179447 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-03-02 | 184086 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-08-04 | 195091 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-04 | 196300 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2023-08-04 | 199527 |
| APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-17 | 2024-02-02 | 210689 |
| APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-24 | 2024-02-09 | 211484 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
| APO-FAMOTIDINE TAB 40MG USP | 40MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 616 |
| APO-FAMOTIDINE TAB 20MG USP | 20 MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 619 |
| APO-FAMOTIDINE | 10MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19048 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-03-12 | 2017-04-17 | 719 |
| APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2017-07-26 | 2018-01-18 | 17234 |
| APO-FAMCICLOVIR | 250MG | TABLET | Resolved | 2017-09-04 | 2018-01-18 | 20872 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |